Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease

Aim. To study the possible relationship between polymorphic variants of ABCB1 (rs2032582, rs1045642, rs1128503), CYP3A5 (rs776746), CYP3A4 (rs35599367) and CYP2J2 (rs890293) genes with residual equilibrium concentrations (Cmin,ss) of rivaroxaban in patients with non-valvular atrial fibrillation (AF)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Столичная издательская компания 2023-11-01
Colecção:	Рациональная фармакотерапия в кардиологии
Assuntos:	atrial fibrillation chronic kidney disease rivaroxaban pharmacokinetics pharmacogenetics
Acesso em linha:	https://www.rpcardio.online/jour/article/view/2970
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!